About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

GlaxoSmithKline’s Asthma Drug ‘Not Cost Effective’: Boston-Based Independent Organization

by Reshma Anand on December 22, 2015 at 12:12 PM
Font : A-A+

GlaxoSmithKline’s Asthma Drug ‘Not Cost Effective’: Boston-Based Independent Organization

The newly launched asthma drug by the London-based drug maker, GlaxoSmithKline (GSK) is not cost-effective, reports an independent nonprofit organization.

The Boston-based organization called Institute for Clinical and Economic Review (ICER) conducts studies on the effectiveness and value of drugs launched by several pharmaceutical companies in the US.

Advertisement


The organization has reported that the GSK's new drug, Nucala for severe asthma should be as much as 76 percent lower to justify its value. The drug should be priced at $7,800 to about $12,000 a year than its current price of $32,500 a year.

GSK won the USFDA's approval for Nucala last month which significantly reduces asthma attacks, symptoms and also decreases the need for oral steroids. The organization indicated that there is uncertainty about whether the benefits will persist over the long term because of the short duration of clinical trials.
Advertisement

ICER President Steven Pearson, said, "Our analyses aim to help the health care community determine what should be used, which patients benefit most, and at what price innovative treatments represent a reasonable value."

GSK's spokeswoman Sarah Spencer said, "We believe that Nucala is fairly priced, balancing innovation and market value with patient access."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Childhood Asthma Drug Toxicity Asthma Signature Drug Toxicity Laser Vision Correction Surgery Remedies for Seasonal Allergy Relief Allergy - Symptom Evaluation Wheezing Churg-Strauss Syndrome 

Most Popular on Medindia

Blood Donation - Recipients Find a Hospital Nutam (400mg) (Piracetam) Sinopril (2mg) (Lacidipine) Noscaphene (Noscapine) How to Reduce School Bag Weight - Simple Tips Loram (2 mg) (Lorazepam) Pregnancy Confirmation Calculator Vent Forte (Theophylline) Daily Calorie Requirements
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

GlaxoSmithKline’s Asthma Drug ‘Not Cost Effective’: Boston-Based Independent Organization Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests